Investigation of a Dipeptidyl Peptidase-4 Inhibitor/Thiazolidinedione Combination Drug for Patients With Type 2 Diabetes and Poor Glycemic Control: Difficulty With Patient Enrollment

BACKGROUND: One of the treatment options for type 2 diabetes mellitus (DM) is a combination drug (CD) that contains the dipeptidyl peptidase-4 inhibitor (DPP4I) alogliptin (AG) together with pioglitazone (PG). This CD can improve impaired insulin secretion and insulin resistance, which are the two m...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamura, Keisuke, Shirai, Kazuyuki, Miyazaki, Motoyasu, Okuda, Tetsu, Takamiya, Yosuke, Goto, Miwa, Urata, Hidenori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340677/
https://www.ncbi.nlm.nih.gov/pubmed/30701000
http://dx.doi.org/10.14740/jocmr3558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340677/
https://www.ncbi.nlm.nih.gov/pubmed/30701000
http://dx.doi.org/10.14740/jocmr3558

Ejemplares similares